vs

Side-by-side financial comparison of N-able, Inc. (NABL) and PROCEPT BioRobotics Corp (PRCT). Click either name above to swap in a different company.

N-able, Inc. is the larger business by last-quarter revenue ($130.3M vs $83.1M, roughly 1.6× PROCEPT BioRobotics Corp). On growth, PROCEPT BioRobotics Corp posted the faster year-over-year revenue change (20.2% vs 11.8%). Over the past eight quarters, PROCEPT BioRobotics Corp's revenue compounded faster (24.8% CAGR vs 7.0%).

Able UK is a British industrial services company specialising in decommissioning of ships and offshore installations.

PROCEPT BioRobotics Corp is a medical tech firm developing and commercializing robotic surgical solutions for urological care. Its flagship AquaBeam system provides image-guided minimally invasive therapy for benign prostatic hyperplasia, serving providers and patients across North America, Europe and global markets.

NABL vs PRCT — Head-to-Head

Bigger by revenue
NABL
NABL
1.6× larger
NABL
$130.3M
$83.1M
PRCT
Growing faster (revenue YoY)
PRCT
PRCT
+8.4% gap
PRCT
20.2%
11.8%
NABL
Faster 2-yr revenue CAGR
PRCT
PRCT
Annualised
PRCT
24.8%
7.0%
NABL

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
NABL
NABL
PRCT
PRCT
Revenue
$130.3M
$83.1M
Net Profit
$-31.6M
Gross Margin
76.2%
64.9%
Operating Margin
10.2%
-4.1%
Net Margin
-38.1%
Revenue YoY
11.8%
20.2%
Net Profit YoY
-27.9%
EPS (diluted)
$-0.04
$-0.56

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
NABL
NABL
PRCT
PRCT
Q1 26
$83.1M
Q4 25
$130.3M
$76.4M
Q3 25
$131.7M
$83.3M
Q2 25
$131.2M
$79.2M
Q1 25
$118.2M
$69.2M
Q4 24
$116.5M
$68.2M
Q3 24
$116.4M
$58.4M
Q2 24
$119.4M
$53.4M
Net Profit
NABL
NABL
PRCT
PRCT
Q1 26
$-31.6M
Q4 25
$-29.8M
Q3 25
$1.4M
$-21.4M
Q2 25
$-4.0M
$-19.6M
Q1 25
$-7.2M
$-24.7M
Q4 24
$-18.9M
Q3 24
$10.8M
$-21.0M
Q2 24
$9.5M
$-25.6M
Gross Margin
NABL
NABL
PRCT
PRCT
Q1 26
64.9%
Q4 25
76.2%
60.6%
Q3 25
77.5%
64.8%
Q2 25
78.1%
65.4%
Q1 25
76.6%
63.9%
Q4 24
80.0%
64.0%
Q3 24
82.9%
63.2%
Q2 24
84.0%
59.0%
Operating Margin
NABL
NABL
PRCT
PRCT
Q1 26
-4.1%
Q4 25
10.2%
-40.6%
Q3 25
8.8%
-27.8%
Q2 25
7.7%
-28.0%
Q1 25
1.5%
-39.7%
Q4 24
13.7%
-28.9%
Q3 24
20.5%
-38.4%
Q2 24
18.4%
-50.3%
Net Margin
NABL
NABL
PRCT
PRCT
Q1 26
-38.1%
Q4 25
-39.1%
Q3 25
1.1%
-25.7%
Q2 25
-3.1%
-24.7%
Q1 25
-6.1%
-35.8%
Q4 24
-27.6%
Q3 24
9.2%
-35.9%
Q2 24
7.9%
-48.0%
EPS (diluted)
NABL
NABL
PRCT
PRCT
Q1 26
$-0.56
Q4 25
$-0.04
$-0.54
Q3 25
$0.01
$-0.38
Q2 25
$-0.02
$-0.35
Q1 25
$-0.04
$-0.45
Q4 24
$0.01
$-0.34
Q3 24
$0.06
$-0.40
Q2 24
$0.05
$-0.50

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
NABL
NABL
PRCT
PRCT
Cash + ST InvestmentsLiquidity on hand
$111.8M
$245.6M
Total DebtLower is stronger
$393.9M
$51.7M
Stockholders' EquityBook value
$804.7M
$347.7M
Total Assets
$1.4B
$487.1M
Debt / EquityLower = less leverage
0.49×
0.15×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
NABL
NABL
PRCT
PRCT
Q1 26
$245.6M
Q4 25
$111.8M
$286.5M
Q3 25
$101.4M
$294.3M
Q2 25
$93.9M
$302.7M
Q1 25
$94.1M
$316.2M
Q4 24
$85.2M
$333.7M
Q3 24
$174.4M
$196.8M
Q2 24
$157.5M
$214.1M
Total Debt
NABL
NABL
PRCT
PRCT
Q1 26
$51.7M
Q4 25
$393.9M
$51.6M
Q3 25
$331.7M
$51.6M
Q2 25
$332.1M
$51.5M
Q1 25
$332.6M
$51.5M
Q4 24
$333.1M
$51.5M
Q3 24
$333.6M
$51.4M
Q2 24
$334.1M
$51.4M
Stockholders' Equity
NABL
NABL
PRCT
PRCT
Q1 26
$347.7M
Q4 25
$804.7M
$365.9M
Q3 25
$813.4M
$380.3M
Q2 25
$809.4M
$385.8M
Q1 25
$775.1M
$389.2M
Q4 24
$759.3M
$402.2M
Q3 24
$765.0M
$241.2M
Q2 24
$724.4M
$251.8M
Total Assets
NABL
NABL
PRCT
PRCT
Q1 26
$487.1M
Q4 25
$1.4B
$508.1M
Q3 25
$1.4B
$511.5M
Q2 25
$1.4B
$513.1M
Q1 25
$1.4B
$519.4M
Q4 24
$1.3B
$534.0M
Q3 24
$1.2B
$374.1M
Q2 24
$1.2B
$374.4M
Debt / Equity
NABL
NABL
PRCT
PRCT
Q1 26
0.15×
Q4 25
0.49×
0.14×
Q3 25
0.41×
0.14×
Q2 25
0.41×
0.13×
Q1 25
0.43×
0.13×
Q4 24
0.44×
0.13×
Q3 24
0.44×
0.21×
Q2 24
0.46×
0.20×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
NABL
NABL
PRCT
PRCT
Operating Cash FlowLast quarter
$25.3M
Free Cash FlowOCF − Capex
$20.9M
FCF MarginFCF / Revenue
16.0%
Capex IntensityCapex / Revenue
3.4%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$75.1M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
NABL
NABL
PRCT
PRCT
Q1 26
Q4 25
$25.3M
$-10.3M
Q3 25
$24.0M
$-6.6M
Q2 25
$24.2M
$-15.0M
Q1 25
$19.7M
$-17.0M
Q4 24
$26.0M
$-32.4M
Q3 24
$22.0M
$-18.8M
Q2 24
$27.3M
$-15.7M
Free Cash Flow
NABL
NABL
PRCT
PRCT
Q1 26
Q4 25
$20.9M
$-12.2M
Q3 25
$17.4M
$-9.5M
Q2 25
$20.4M
$-17.8M
Q1 25
$16.4M
$-18.8M
Q4 24
$18.8M
$-33.6M
Q3 24
$18.2M
$-19.0M
Q2 24
$24.0M
$-16.8M
FCF Margin
NABL
NABL
PRCT
PRCT
Q1 26
Q4 25
16.0%
-15.9%
Q3 25
13.2%
-11.4%
Q2 25
15.5%
-22.5%
Q1 25
13.9%
-27.2%
Q4 24
16.2%
-49.2%
Q3 24
15.7%
-32.6%
Q2 24
20.1%
-31.4%
Capex Intensity
NABL
NABL
PRCT
PRCT
Q1 26
Q4 25
3.4%
2.4%
Q3 25
5.0%
3.4%
Q2 25
2.9%
3.5%
Q1 25
2.8%
2.7%
Q4 24
6.1%
1.7%
Q3 24
3.2%
0.4%
Q2 24
2.7%
2.0%
Cash Conversion
NABL
NABL
PRCT
PRCT
Q1 26
Q4 25
Q3 25
17.36×
Q2 25
Q1 25
Q4 24
Q3 24
2.04×
Q2 24
2.89×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

NABL
NABL

Transferred Over Time$121.9M94%
Transferred At Point In Time$8.4M6%
Other Revenue$1.3M1%

PRCT
PRCT

Handpieces and other consumables$43.0M52%
System sales and rentals$23.4M28%
Other$11.1M13%
Service$5.6M7%

Related Comparisons